Mihály Bak

415 total citations
23 papers, 335 citations indexed

About

Mihály Bak is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Mihály Bak has authored 23 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 11 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Mihály Bak's work include Testicular diseases and treatments (11 papers), Drug Transport and Resistance Mechanisms (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Mihály Bak is often cited by papers focused on Testicular diseases and treatments (11 papers), Drug Transport and Resistance Mechanisms (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Mihály Bak collaborates with scholars based in Hungary, Germany and France. Mihály Bak's co-authors include I. Bodrogi, Lajos Géczi, M Volm, Eric Hahn, Frédéríc Gomez, Orsolya Csuka, Thomas Efferth, Miklós Kásler, József Tóth and J Mattern and has published in prestigious journals such as The Journal of Pathology, Cancer and Metastasis Reviews and Oncology Reports.

In The Last Decade

Mihály Bak

23 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mihály Bak Hungary 12 157 152 119 56 42 23 335
Jian Gu China 10 78 0.5× 167 1.1× 71 0.6× 54 1.0× 24 0.6× 20 310
Eric Casal Ide Italy 14 131 0.8× 129 0.8× 104 0.9× 58 1.0× 75 1.8× 18 486
Takeshi Namekawa Japan 10 116 0.7× 167 1.1× 115 1.0× 160 2.9× 19 0.5× 18 432
Koji Sekikawa Japan 6 71 0.5× 116 0.8× 154 1.3× 42 0.8× 41 1.0× 34 342
Belma Kurdoglu United States 8 49 0.3× 147 1.0× 200 1.7× 65 1.2× 21 0.5× 9 468
M. Zahurak United States 7 84 0.5× 183 1.2× 85 0.7× 41 0.7× 13 0.3× 12 373
Natalia Ramírez-Merino Spain 6 107 0.7× 160 1.1× 236 2.0× 72 1.3× 19 0.5× 7 361
Enrica Testa Italy 7 85 0.5× 182 1.2× 122 1.0× 95 1.7× 18 0.4× 10 328
Jole Ventriglia Italy 13 68 0.4× 111 0.7× 369 3.1× 96 1.7× 18 0.4× 36 547
Yoshio Tokuchi Japan 10 45 0.3× 205 1.3× 237 2.0× 139 2.5× 51 1.2× 16 431

Countries citing papers authored by Mihály Bak

Since Specialization
Citations

This map shows the geographic impact of Mihály Bak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mihály Bak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mihály Bak more than expected).

Fields of papers citing papers by Mihály Bak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mihály Bak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mihály Bak. The network helps show where Mihály Bak may publish in the future.

Co-authorship network of co-authors of Mihály Bak

This figure shows the co-authorship network connecting the top 25 collaborators of Mihály Bak. A scholar is included among the top collaborators of Mihály Bak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mihály Bak. Mihály Bak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kelemen, P. B., Eszter Kovács, István Kenessey, et al.. (2018). Barriers to Organized Mammography Screening Programs in Hungary: A Questionnaire-based Study of 3,313 Women. Anticancer Research. 38(3). 1727–1734. 3 indexed citations
2.
Kelemen, P. B., Ákos Sávolt, Mária Gődény, et al.. (2016). A European Society of Breast Cancer Specialists (EUSOMA) előírásainak megfelelő emlőrákellátás minőségbiztosítási elemzése az Országos Onkológiai Intézetben | Breast cancer care quality analysis of the National Institute of Oncology in Hungary according to the requirements of European Society of Breast Cancer Specialists (EUSOMA). 1 indexed citations
3.
Bak, Mihály, Eszter Kovács, F Rényi-Vámos, et al.. (2012). Quality assurance of rapid on-site evaluation of CT-guided fine-needle aspiration cytology of lung nodules. Orvosi Hetilap. 154(1). 28–32. 4 indexed citations
4.
Nuti, Francesca, Paola Luciani, Eliana Marinari, et al.. (2009). Seladin‐1 and testicular germ cell tumours: new insights into cisplatin responsiveness. The Journal of Pathology. 219(4). 491–500. 11 indexed citations
5.
Szende, Béla, et al.. (2008). Apoptosis regulation and spontaneous apoptosis index of testicular germ cell tumors are associated with differentiation and resistance to systemic treatment.. PubMed. 28(3A). 1641–9. 8 indexed citations
6.
Remenár, Éva, et al.. (2007). RARβ2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age. Oncology Reports. 18(1). 105–12. 10 indexed citations
7.
Géczi, Lajos, et al.. (2006). Influence of hMLH1 methylation, mismatch repair deficiency and microsatellite instability on chemoresistance of testicular germ-cell tumors.. PubMed. 25(6B). 4319–24. 31 indexed citations
8.
Bak, Mihály, et al.. (2005). [The "gray zone" in fine needle aspiration cytology of the breast].. PubMed. 58(1). 3–7. 4 indexed citations
9.
Géczi, Lajos, Zoltán Doleschall, I. Bodrogi, et al.. (2004). Expression and prognostic value of the lung resistance-related protein (LRP) in germ cell testicular tumors.. PubMed. 24(2C). 1097–104. 6 indexed citations
10.
Géczi, Lajos, I. Bodrogi, József Tóth, et al.. (2004). Clinical relevance of HER-2/neu expression in germ-cell testicular tumors.. PubMed. 24(4). 2219–24. 15 indexed citations
11.
Géczi, Lajos, et al.. (2003). Expression of HER-2/neu in testicular tumors.. PubMed. 23(4). 3447–51. 14 indexed citations
12.
Géczi, Lajos, Frédéríc Gomez, Mihály Bak, & I. Bodrogi. (2003). The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary. Journal of Cancer Research and Clinical Oncology. 129(5). 309–315. 34 indexed citations
13.
Géczi, Lajos, et al.. (2002). [Lung resistance protein analysis in testicular cancer].. PubMed. 46(4). 339–45. 1 indexed citations
14.
Bodrogi, I., et al.. (2001). MRP expression of testicular cancers and its clinical relevance.. PubMed. 20(5C). 4019–22. 7 indexed citations
15.
Géczi, Lajos, Frédéríc Gomez, Zsolt Horváth, et al.. (2001). Three-Year Results of the First Educational and Early Detection Program for Testicular Cancer in Hungary. Oncology. 60(3). 228–234. 11 indexed citations
16.
Géczi, Lajos, et al.. (2000). mdm-2 expression in human testicular germ-cell tumors and its clinical value.. PubMed. 19(4C). 3485–90. 19 indexed citations
17.
Géczi, Lajos, et al.. (1998). Do metallothioneins affect the response to treatment in testis cancers?. Journal of Cancer Research and Clinical Oncology. 124(1). 31–36. 13 indexed citations
18.
Volm, M, Thomas Efferth, Mihály Bak, Anthony D. Ho, & Jürgen Mattern. (1989). Detection of the multidrug resistant phenotype in human tumours by monoclonal antibodies and the streptavidin-biotinylated phycoerythrin complex method. European Journal of Cancer and Clinical Oncology. 25(4). 743–749. 23 indexed citations
19.
Volm, M, Mihály Bak, Thomas Efferth, & J Mattern. (1989). Induced multidrug resistance in murine leukemia L1210 and associated changes in a surface-membrane glycoprotein. Journal of Cancer Research and Clinical Oncology. 115(1). 17–24. 18 indexed citations
20.
Bak, Mihály, et al.. (1988). Human tumor xenografts as model for drug testing. Cancer and Metastasis Reviews. 7(3). 263–284. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jian Gu Breakdown of academic impact, for papers by Eric Casal Ide Breakdown of academic impact, for papers by Takeshi Namekawa Breakdown of academic impact, for papers by Koji Sekikawa Breakdown of academic impact, for papers by Belma Kurdoglu Breakdown of academic impact, for papers by M. Zahurak Breakdown of academic impact, for papers by Natalia Ramírez-Merino Breakdown of academic impact, for papers by Enrica Testa Breakdown of academic impact, for papers by Jole Ventriglia Breakdown of academic impact, for papers by Yoshio Tokuchi
Rankless by CCL
2026